This document discusses abortion, also known as miscarriage. Abortion is defined as the termination of a pregnancy by removing the fetus or embryo before it can survive outside the uterus. The document covers the incidence, classification, etiology, signs and symptoms, investigations, and management of different types of miscarriages such as threatened, inevitable, incomplete, missed, septic, and recurrent miscarriages. Nursing management involves close monitoring of symptoms and vital signs and notifying the healthcare provider immediately if bleeding is noticed.
Hydatidiform Mole (HM) is a rare mass or growth that forms inside the uterus at the beginning of a pregnancy. It is a type of gestational trophoblastic disease (GTD).
When a normal sperm cell fertilizes one of these oocytes, the resulting embryo has only one set of chromosomes. Because the embryo has no genes from the mother, the pregnancy cannot develop normally, resulting in a hydatidiform mole.
Hydatidiform Mole (HM) is a rare mass or growth that forms inside the uterus at the beginning of a pregnancy. It is a type of gestational trophoblastic disease (GTD).
When a normal sperm cell fertilizes one of these oocytes, the resulting embryo has only one set of chromosomes. Because the embryo has no genes from the mother, the pregnancy cannot develop normally, resulting in a hydatidiform mole.
The second stage of labor begins when the cervix is completely dilated (open), and ends with the birth of your baby. Contractions push the baby down the birth canal, and you may feel intense pressure, similar to an urge to have a bowel movement. Your health care provider may ask you to push with each contraction.
Placenta previa is a condition in which the placenta lies very low in the uterus and covers all or part of the cervix. The cervix is the opening to the uterus that sits at the top of the vagina. Placenta previa happens in about 1 in 200 pregnancies.
Placenta praevia risk factors include a previous delivery, age older than 35 and a history of previous surgeries, such as a caesarean section (C-section) or uterine fibroid removal.
The main symptom is bright red vaginal bleeding without pain during the second-half of pregnancy. The condition can also cause severe bleeding before or during delivery.
Limited physical activity is recommended. A C-section is often required in severe cases.
This topic contains detailed description regarding Normal puerperium, it's definition, duration, phases, involution of uterus and other pelvic organs, lochia, general physiological changes of puerperium, lactation, management of normal puerperium, management of ailments and postnatal care.
The second stage of labor begins when the cervix is completely dilated (open), and ends with the birth of your baby. Contractions push the baby down the birth canal, and you may feel intense pressure, similar to an urge to have a bowel movement. Your health care provider may ask you to push with each contraction.
Placenta previa is a condition in which the placenta lies very low in the uterus and covers all or part of the cervix. The cervix is the opening to the uterus that sits at the top of the vagina. Placenta previa happens in about 1 in 200 pregnancies.
Placenta praevia risk factors include a previous delivery, age older than 35 and a history of previous surgeries, such as a caesarean section (C-section) or uterine fibroid removal.
The main symptom is bright red vaginal bleeding without pain during the second-half of pregnancy. The condition can also cause severe bleeding before or during delivery.
Limited physical activity is recommended. A C-section is often required in severe cases.
This topic contains detailed description regarding Normal puerperium, it's definition, duration, phases, involution of uterus and other pelvic organs, lochia, general physiological changes of puerperium, lactation, management of normal puerperium, management of ailments and postnatal care.
OBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptxmagie12
The students will be able to
*define abortion
*Identify the difference between various types of abortion
*Perform medical induction for abortion
*Describe various surgical techniques used for abortion
*Detect the consequences that occur by abortion and provide appropriate care
Abortion or pregnancy loss is accounts to spontaneous events or through legal termination.
The first large scale study on abortions and unintended pregnancies conducted by The Lancet in 2017 said one in three of the 48.1 million pregnancies in India end in an abortion with 15.6 million taking place in 2015.
*Definition
*Types of abortion- Spontaneous, Induced, Complete abortion, Incomplete abortion, Missed abortion, Recurrent abortion, Induced abortion
*Risk factors,
*etiology, mechanism,
* clinical manifestations of each type
*Management – medical & surgical
Nursing management
Abortion is the expulsion or extraction from its mother of an embryo or fetus weighing 500 gm or less when it is not capable of independent survival
-WHO
The 500gm of fetal development is attained
approximately at 22 weeks(154 days of gestation).
The expelled embryo or fetus is called abortus
Abortion is the cause for bleeding in early pregnancy.
Abortion occurring without medical or mechanical means to empty the uterus is referred to as spontaneous.
Another widely used term is miscarriage.
10-20% of cases of all clinical pregnancies end in miscarriage.
About 75%miscarriages –before 16th week
About 80% occur –before 12th week of pregnancy.
Increases with parity
Increased maternal and paternal age
The frequency of abortion increases from 12% in women younger than 20 years to 26% in those older than 40 years
Women conceiving within 3 months following a term birth, have a higher incidence of abortion
Anembryonic Gestational sac
- Positive HCG test as placenta secretes HCG and stops later
Presents in first few weeks of pregnancy
Removal through medical or surgical induction
Uncommon causes of abortion in human
Listeria monocytogenes
Clamydia trachomatis
Mycoplasma hominis
Ureaplasma urealyticum
Toxoplasma gondii
Diabetes mellitus
Celiac sprue
Cause both male and female infertility and recurrent abortions
ENDOCRINE ABNORMALITIES
Hypothyroidism
Thyroid autoantibodies → incidence of abortion is high
Diabetes mellitus
Poor glucose control → incidence of abortion increased
Progesterone deficiency
Luteal phase defect
Insufficient progesterone secretion by the corpus luteum or placenta
DRUG USE AND ENVIRONMENTAL FACTORS
Recurrent pregnancy loss patients : 15%
Antiphospholipid antibody : most significant
LCA (lupus anticoagulant), ACA (anticardiolipin Ab)
ALLOIMMUNE FACTORS
- Inherited thrombophilia
Uterine synechiae (Asherman syndrome)
Partial or complete obliteration of the uterine cavity by adherence of uterine wall
The retention power of the cervix(Internal os) may be impaired functionally and or anatomically in an incompetent cervix
Etiology
Previous trauma during pregnancy
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. • *Abortion is also called as
miscarriage.
•
* Abortion is ending of
pregnancy by removing a foetus
or embryo before it can survive
outside the uterus.
3. DEFINITION:
* Abortion is the expulsion or
extraction from its mother of
an embryo or foetus weghing
500gm
or less when it is not capable
of independent survival (Acc.
WHO)
4. INCIDENCE :
* The incidence of abortion is
difficult to work out but probably
10-20% of all clinical pregnancies
end in miscarriage and another
optmistic figure of 10% are
induced or deliberate About 75%
miscarriages occur before the
16th week of pregnancy.
6. ETIOLOGY:
The etiology of miscarriage if
often complex and obscure. The
following factors are important:
Genetic
Anatomic
Immunological
Infection
Endocrinal
7. THREATENED MISCARRIAGE :
It is a clinical entity where the
process of miscarriage has
started but has not progressed to
a state from which recovery is
possible
C/M : painless vaginal bleeding
without vaginal contraction, mild
abdominal pain.
10. INEVITABLE MISCARRIAGE:
Definition:- it is the clinical type
of abortion where the changes
have progressed to a state from
where continuation of pregnancy
is impossible
Clinical Features :- Increased
vaginal bleeding ,aggravation of
colicky pain , dilated internal os
11.
12. TREATEMENT:-
Before 12 Weeks:- Dilation and
Evacuation followed by cruttage of
uterine cavity
After 12 Weeks :- The uterine
contraction is accelerated by
oxytocin drip 40-60 drops per minute
if the foteus is explled and placenta
is retained then D&E is done under
general anesthesia
13. COMPLETE MISCARRIAGE
A complete miscarriage is
defined as a cessation of
vaginal bleeding with no
evidence of retained products of
conception or a gestation sac in
a woman who previously had
an ultrasound confirmed
intrauterine pregnancy
16. INCOMPLETE MISCARRIAGE
A miscarriage is labeled "incomplete"
if bleeding has begun and the cervix
is dilated, but tissue from the
pregnancy still remains in the uterus.
17. Clinical Features:- Continuation
of pain in lower abdomen ,
vaginal bleeding, patulous
cervical often admiting tip of the
finger , usg shows echogenic
material within cavity
Management :- D&E , tablet
misoprostol 200mg is used
vaginally evey 4 hrs
18. MISSED MISCARRIAGE
When the foetus is dead and retained
inside the uterus for a variable period
it is called missed miscarriage or
early fetal demise
Clinical Features:- Persistence of
vaginal brownish discharge,
Subsidence of pregnancy symptoms
,nonaudibility of FHS even with
doppler ultrasound ,USG shows an
sac with absence of any fetal
movements or cardiac motion
19.
20. MANAGEMENT:-
When uterus is less than 12 weeks
many women expel the product
spontaneously
Prostaglandin E1 800mg vaginally
for expulsion
S&E ,D&E is done either as definitive
treatment
When uterus more than 12 weeks:-
10-20 units of oxytocin in 500ml of
NS at 30 drops/min Many pt. needs
21. SEPTIC ABORTION
Definition:- Any abortion associated
with clinical evidences of infection of
the uterus and its content is called
septic abortion
Mode of Infection :- Through
microorganisms which are anaerobic
bacteriodes, streptococci,colstridium
welchii , pseudomonas escheria coli
mrthicillin resistant stayphylococcus
aureus
22. PATHOLOGY:-
In the majority the organisms are
endogenous origin and the infection
is localised to the conceptus without
any myometrial involvement in about
15% the infection either produces
localized endometritis surrounded by
a protective leukocytic barrier or
spreads to the parametrium
tubes,ovaries in about 5% there is
generalized peritonitis or endotoxic
23. CLINICAL FEATURES
The women looks sick and anxious
Chills and rigors
Hypothermia
Abdominal pain
Renal angle tenderness
Offensive purulent vaginal
discharge
24. INVESTIGATIONS
Routine investigations include:- swab
culuture to find out the dominant
microorganisms,senstivity of
microorganisms to antibiotics and smear
for gram stain
Urine Analysis including culture
Blood for HB and count of WBCs
Plain X-RAY :- To suspect bowel injury
USG:- To detect the any products in cavity,
fluid accumulation in pouch of Douglas
25. MANAGEMENT
Hospitalization is essential for cases
of septic abortion
To take high vaginal or cervical swab
for culture
Vaginal examination is done to note
the state of the abortion proces and
extension of infection
Antibiotics and Analgesics
Evacuation of uterus
Posterior Colpotomy
26. RECURRENT MISCARRIAGE
Definition:- It is defined as the
sequence of two or more
spontaneous abortion as
documented by sonography
before 20 weeks of gestation
Etiology:- Genetic factors
,endocrine and metabolic
,infections inherited
thrombophillia, immune factors
27. NURSING MANAGEMENT
The presenting symptom of an abortion is
always vaginal spotting, and once this is
noticed by the pregnant woman, she
should immediately notify her healthcare
provider
Ask of the pregnant woman’s actions
before the spotting or bleeding occurred
and identifies the measures she did when
she first noticed the bleeding.
Inquire of the duration and intensity of the
bleeding or pain felt. Lastly, identify the
client’s blood type for cases of Rh
incompatibility.